Anderson Study 1 - Tart Cherry Study (NCT04837274) | Clinical Trial Compass
CompletedNot Applicable
Anderson Study 1 - Tart Cherry Study
United States24 participantsStarted 2020-04-10
Plain-language summary
The purpose of this study is to examine if tart cherry reduces food-induced elevations in serum uric acid.
Who can participate
Age range30 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* They are healthy males or females ages 30 to 60 years with fasting serum uric acid (UA) levels between 5.5 and 8.0 mg/dl obtained during the familiarization/screening visit;
* They have a willingness to provide voluntary, written, informed consent to participate in the study;
Exclusion Criteria:
* They take prescription (Rx) medications (i.e., Uloric, Krystexxa, etc.) or dietary supplements known to have UA-reducing activity (i.e., black cherry, devil's claw, grape seed extracts, etc.);
* They have regular diseases requiring regular prescription (Rx) medications (birth control is allowed);
* They have abnormal/out of range values in laboratory tests determined at the familiarization/screening visit;
* They have an allergy to tart cherry or immunoglobulin E;
* They are pregnant, trying to become pregnant or breastfeeding;
What they're measuring
1
Uric Acid Changes
Timeframe: Measured at baseline (prior to supplementation (Pre)), and after 60, 120, 180 and 240 minutes